MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $63,451 | -41.6% | 400,826 | 0.0% | 0.01% | -50.0% |
| Q1 2024 | $108,624 | +25.3% | 400,826 | 0.0% | 0.01% | +9.1% |
| Q4 2023 | $86,659 | +66.3% | 400,826 | 0.0% | 0.01% | +57.1% |
| Q3 2023 | $52,107 | -63.9% | 400,826 | 0.0% | 0.01% | -63.2% |
| Q2 2023 | $144,297 | -23.4% | 400,826 | 0.0% | 0.02% | -32.1% |
| Q1 2023 | $188,388 | -5.8% | 400,826 | 0.0% | 0.03% | -12.5% |
| Q4 2022 | $200,000 | -21.6% | 400,826 | 0.0% | 0.03% | -23.8% |
| Q3 2022 | $255,000 | -19.6% | 400,826 | 0.0% | 0.04% | +2.4% |
| Q2 2022 | $317,000 | -1.6% | 400,826 | 0.0% | 0.04% | -12.8% |
| Q1 2022 | $322,000 | -20.5% | 400,826 | 0.0% | 0.05% | -17.5% |
| Q4 2021 | $405,000 | -22.3% | 400,826 | 0.0% | 0.06% | -28.8% |
| Q3 2021 | $521,000 | +67.5% | 400,826 | 0.0% | 0.08% | +60.0% |
| Q2 2021 | $311,000 | -26.1% | 400,826 | 0.0% | 0.05% | -33.3% |
| Q1 2021 | $421,000 | -22.8% | 400,826 | 0.0% | 0.08% | -32.4% |
| Q4 2020 | $545,000 | – | 400,826 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
| Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
| Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
| Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
| Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
| Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
| STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
| CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
| BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |